Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transdermal Nicotine and Bupropion for Smoking in Schizophrenics (Study 1)

NCT00218218 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT00218218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00218218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transdermal Nicotine and Bupropion for Smoking in Schizophrenics (Study 1)
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2002
Completion date
February 28, 2005
Enrollment
48 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, schizophrenia and disorders with psychotic features, tobacco use disorder